Jessica H.
- Country
- Germany
- Department
- 4500: Nationales Centrum für Tumorerkrankungen
Research Overview
- Evaluation of PF-08046049/SGN-BB228 in Patients with Advanced Pancreatic, Colorectal, Non-Small Cell Lung, Mesothelioma, and Cutaneous Melanoma Neoplasms
- A Phase 3, Randomized, Open-label, Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination versus Intravenous Nivolumab + Relatlimab Fixed-dose Combination in Participants with Previously Untreated Metastatic or Unresectable Melanoma
- A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study of Adjuvant MK-7684A (Vibostolimab with Pembrolizumab) Versus Adjuvant Pembrolizumab in Participants with High-risk Stage II-IV Melanoma (KEYVIBE-010)
Data & Insights
Has run more than one trial at 181 of 302 partner sites.
Specializations
Melanoma Research
The investigator specializes in various forms of melanoma treatment, with particular focus on advanced and metastatic cases. Their research encompasses both cutaneous melanoma and uveal melanoma interventions.
- Advanced Metastatic Melanoma
- BRAF-Mutated Melanoma
- Unresectable Melanoma
Expertise extends to both adjuvant and neoadjuvant therapeutic approaches for melanoma management.
Immunotherapy Innovation
Leading research in novel immunotherapy combinations and targeted treatments, particularly focusing on checkpoint inhibitors and innovative therapeutic combinations.
- Checkpoint Inhibitor Therapy
- Combination Immunotherapy
- Targeted Molecular Treatments
Investigates cutting-edge immunological approaches for skin cancer treatment.
Skin Cancer Specialization
Conducts research in various forms of non-melanoma skin cancers, with particular emphasis on advanced cases requiring innovative therapeutic approaches.
- Cutaneous Squamous Cell Carcinoma
- Basal Cell Carcinoma
- Advanced Skin Malignancies
Focuses on developing treatment strategies for complex and aggressive skin cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.